31 Mar 2020
Assets22.45
Total Income39.42
Profit After Tax0.93
NET Worth4.25
Reserves and Surplus0.00
Total Borrowing5.66
Open · Close · Listing
Infinium Pharmachem is a SME IPO with an issue size of ₹25.25 crore, proposed for listing on NSE SME. The issue structure includes a fresh issue of ₹23.99 crore.
| Object | Amount |
|---|---|
| Marketing and Branding Expenses (including Registration in Reach - Europe, other marketing expenses) | ₹1.13 Cr |
| Repayment of some of Existing Loans; | ₹3.92 Cr |
| Expansion of Existing Unit | ₹5.05 Cr |
| To Meet Incremental Working Capital Requirements; | ₹10.10 Cr |
| General Corporate Purpose | ₹4.43 Cr |
| KPI | Mar 31, 2022 |
|---|---|
| ROE | 43.85% |
| ROCE | 72% |
| Debt / Equity | 2.91% |
| RoNW | 46.61% |
| PAT Margin | 6.16% |
| EBITDA Margin | 11.06% |
| Expense | Amount |
|---|---|
| Lead Manger Fees including Underwriting Commission | ₹0.25 Cr |
| Fees Payable to Registrar to the Issue | ₹0.01 Cr |
| Fees Payable Advertising, Marketing Expenses and Printing Expenses | ₹0.25 Cr |
| Fees Payable to Regulators including Stock Exchanges and other Intermediaries | ₹0.04 Cr |
| Fees payable to Peer Review Auditor, Legal Advisor and Other Professional | ₹0.03 Cr |
| Fees Payable to Market Maker (for Two Years). | ₹0.05 Cr |
| Escrow Bank Fees | ₹0.00 Cr |